Press

See TrippBio in the news

Keep up with current advancements and trials.

TrippBio announces publication of data supporting the antiviral potency of TD-213 against SARS-CoV-2

TrippBio, Inc. announces David E. Martin, PharmD as New President and Chief Executive Officer

Dr. Tripp Joins the FDA Advisory Committee

TrippBio – The WOW is Launched